Blydt-Hansen, I., Bech, M., & Jackson, S. (2025). Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program. Journal of Hematology, 14(5), 257-261. https://doi.org/10.14740/jh2113